| |||||||||||
Nucleic acid amplification testing detects extragenital STIs missed by cultures in young HIV-infected patients Medscape Medical News Share ![]() ![]() ![]() ![]() Nucleic acid amplification testing (NAAT) for gonorrhea and chlamydia at extragenital sites might detect more positive cases than does the use of cultures at these sites, according to a new study. More ![]() How can labs improve implementation, tackle compliance challenges? Clinical Laboratory News Share ![]() ![]() ![]()
For at least a decade, point-of-care testing has been the darling of the medical diagnostics industry, with sustained growth in testing volume and continual technological breakthroughs. The trend shows no sign of abating, as drivers such as the need for hospitals and clinics to better manage capacity and improve care, coupled with further innovations, are making POCT ever more attractive. Yet hospitals and health systems continue to experience challenges in implementing and sustaining POCT programs, at times leaving both laboratorians and clinicians frustrated and wary about the process. The reasons for less-than-satisfactory outcomes are as varied as the programs themselves, but experts cite many factors that can make or break a POCT application. More Human cells exhibit foraging behavior like amoebae and bacteria Science Daily Share ![]() ![]() ![]()
When cells move about in the body, they follow a complex pattern similar to that which amoebae and bacteria use when searching for food, a team of Vanderbilt University researchers in Nashville, Tenn., has found. More Scientists find "mother" of all skin cells Reuters Share ![]() ![]() ![]()
Scientists have found the "mother," or origin, of all skin cells and say their discovery could dramatically improve skin treatments for victims of serious wounds and burns. Hans Clevers and a team of Dutch and Swedish researchers conducted a study in mice and found that the stem cell that gives produces all the different cells of the skin actually lives in hair follicles. More ![]() WHO unveils landmark anti-malaria measures Agence France-Presse via Google News Share ![]() ![]() ![]()
The World Health Organization unveiled landmark new measures to counter the misuse of anti-malaria drugs, which is threatening attempts to stifle some 250 million cases a year of the disease. The UN health agency recommended that all suspected cases of the mosquito-borne disease should be tested and diagnosed before treatment is given, instead of relying simply on identifying symptoms such as fever. More Disease cause is pinpointed with genome The New York Times Share ![]() ![]() ![]()
Two research teams have independently decoded the entire genome of patients to find the exact genetic cause of their diseases. The approach may offer a new start in the so far disappointing effort to identify the genetic roots of major killers like heart disease, diabetes and Alzheimer's. More Despite flu fear, cases are few The Miami Herald Share ![]() ![]() ![]()
Swine flu came in like a lion but seems to be going out like a lamb. And the regular flu season never even got started. After scaring the bejeebers out of us last spring and fall, the H1N1 virus seems to have collapsed by the end of the year. More
Long-term bisphosphonate use linked to abnormal bone formation Medscape Medical News Share ![]() ![]() ![]()
An unusual type of bone fracture has been reported in women who have taken bisphosphonates for osteopenia and osteoporosis for more than four years, according to two studies reported here at the American Association of Orthopaedic Surgeons 2010 Annual Meeting. "Bisphosphonates are wonderful drugs," said Joseph Lane, MD, chief of the Metabolic Bone Service at the Hospital for Special Surgery. "They've cut the vertebral fracture rate by 70 percent and the hip fracture rate by 50 percent. People die from hip fractures." More Newer genetic test for autism more effective HealthDay News via U.S. News & World Report Share ![]() ![]() ![]()
A newer type of genetic test is better at detecting abnormalities that predispose a child to autism than standard genetic tests, new research has determined. Researchers offered about 933 people aged 13 months to 22 years who had been diagnosed with an autism spectrum disorder three genetic tests: G-banded karyotype testing, fragile X testing or chromosomal microarray analysis, which has been available only for the past few years. More |
| ||||||||||
| |||||